Lv1
10 积分 2025-02-04 加入
Antibody–Drug Conjugates: An Emerging Concept in Cancer Therapy
23天前
已完结
Antibody–drug conjugates: current status and future directions
23天前
已完结
Strategies and challenges for the next generation of antibody–drug conjugates
23天前
已完结
Treatment of HER2-positive breast cancer: current status and future perspectives
24天前
已完结
Targeting HER2 in the treatment of non-small cell lung cancer
24天前
已完结
Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis
1个月前
已完结
Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): first interim results from a randomised, double-blind, multicentre, phase 3 trial
1个月前
已完结
Targeted Therapy and Checkpoint Immunotherapy in Lung Cancer
1个月前
已完结
Role of CTLA Inhibition in Management of Non-Small Cell Lung Cancer
1个月前
已完结
老年晚期非小细胞肺癌免疫检查点抑制剂治疗中国专家共识（2025版）
1个月前
已完结
皖公网安备34019202002308
